Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outset Medical (OM) Equity Average (2019 - 2025)

Outset Medical (OM) has disclosed Equity Average for 7 consecutive years, with $134.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Equity Average rose 260.82% to $134.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $134.7 million, a 260.82% increase, with the full-year FY2025 number at $76.9 million, up 2.72% from a year prior.
  • Equity Average was $134.7 million for Q4 2025 at Outset Medical, down from $148.6 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $420.5 million in Q3 2021 to a low of $37.3 million in Q4 2024.
  • A 5-year average of $215.4 million and a median of $183.6 million in 2023 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: surged 4051.22% in 2021, then crashed 72.85% in 2024.
  • Outset Medical's Equity Average stood at $391.9 million in 2021, then crashed by 33.01% to $262.5 million in 2022, then crashed by 47.64% to $137.5 million in 2023, then plummeted by 72.85% to $37.3 million in 2024, then surged by 260.82% to $134.7 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Equity Average are $134.7 million (Q4 2025), $148.6 million (Q3 2025), and $162.3 million (Q2 2025).